NEW YORK (GenomeWeb) – Veracyte has appointed Cepheid Chairman and CEO John Bishop to its board of directors. He also will join the board's compensation committee. Bishop replaces Samuel Colella, who resigned from the board, effective Nov. 30.
Bishop has a long track record in the molecular diagnostics industry, previously serving as president and CEO of Vysis, which was acquired by Abbott Laboratories; chairman and CEO of MicroProbe; and president and COO of Gen-Probe, among other executive positions.
Thermo Fisher Scientific Senior Vice President and Chief Commercial Officer Edward Pesicka is retiring from the company, effective March 31, 2015. He joined Thermo Fisher in 2000 as vice president, controller of Fisher Scientific's US research business. After Fisher and Thermo merged in 2006, Pesicka was named president of the research market business.
Vanderbilt University has appointed Nancy Cox the founding director of the new Vanderbilt Genetics Institute, effective Jan. 1, 2015. She also will be a professor of genetics and direct the division of genetic medicine in the department of medicine.
Cox is currently a professor of medicine and human genetics and the chief of the section of genetic medicine at the University of Chicago. She received her PhD in human genetics from Yale University.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail your announcements to [email protected]